Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base [Breast Cancer]
Conclusion
Neoadjuvant chemotherapy is given more frequently to black, Hispanic, and Asian women than to white women. Black women have a lower likelihood of pCR for triple-negative and HER2-positive breast cancer. Whether this is due to biologic differences in chemosensitivity or to treatment or socioeconomic differences that could not be adjusted for is unknown.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Killelea, Yang, Wang, Hayse, Mougalian, Horowitz, Chagpar, Pusztai, Lannin Tags: Epidemiology, Chemotherapy Breast Cancer Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Education | Epidemiology | HER2 | Insurance | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Universities & Medical Training | Women